
- Oncology NEWS International Vol 11 No 6
- Volume 11
- Issue 6
Medicare to Pay for Image Guidance in Biopsy of Palpable Breast Lesions
WASHINGTON-Medicare will soon cover image guidance techniques, such as stereotactic systems and ultrasound, used to biopsy palpable breast lesions that are difficult to biopsy with palpitation alone. However, contractors who administer Medicare benefits "have the discretion to decide what types of palpable lesions are difficult to biopsy using palpitation," the Centers for Medicare and Medicaid Services said. The new coverage will begin later this year and will not be retroactive. Medicare has covered image guidance to assist the biopsy of nonpalpable lesions since 1999.
WASHINGTONMedicare will soon cover image guidance techniques, such as stereotactic systems and ultrasound, used to biopsy palpable breast lesions that are difficult to biopsy with palpitation alone. However, contractors who administer Medicare benefits "have the discretion to decide what types of palpable lesions are difficult to biopsy using palpitation," the Centers for Medicare and Medicaid Services said. The new coverage will begin later this year and will not be retroactive. Medicare has covered image guidance to assist the biopsy of nonpalpable lesions since 1999.
Articles in this issue
over 23 years ago
Gleevec Effective as First-Line Therapy of CML: IRIS Trialover 23 years ago
Curcumin May Enhance TRAIL-Induced Cancer Cell Deathover 23 years ago
Symptom Clusters or Groupings Are Common in Cancer Outpatientsover 23 years ago
Allogeneic BMT Ups 5-Year EFS in Ph- ALLover 23 years ago
HIV-1 Vaccine Proving Safe, Immunogenic in Humansover 23 years ago
ACS to Fight Tobacco ‘Pandemic’ Worldwideover 23 years ago
Aspirin Helps Prevent Recurrent Large Bowel AdenomasNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































